Where Innovation Meets Capital
2026 Cooley Capital Call @ DHIS
Cooley Capital Call at DHIS will feature seven presentations from innovative seed- to Series A-stage digital health companies. Each finalist will present a rapid-fire pitch, followed by a Q&A with the judges and venture capitalists. Roy Moran, Partner, Cooley will host the 2026 Cooley Capital Call on April 27th, announce and interview the winning company on Tuesday, April 28th
Meet the Finalists
All4Cure
Revolutionizing Cancer Care: All4Cure has developed the first-of-its-kind Collaborative Ecosystem for Oncology (CEO) to bridge the researcher-clinician-patient gap. We unify real-time, best-in-class patient data, cutting-edge analytics, expert decision support, and an intuitive dashboard into a single treatment optimization platform for patients and clinicians. www.all4cure.com
Azodha
Healthcare is shifting to home, and Azodha is the AI Operating System for Decentralized Care Delivery — orchestrating operations and logistics so care programs can scale seamlessly beyond four walls. www.azodha.com
ClariVue Health
ClariVue Health is the first end-to-end system of record
for infusion care — starting at diagnosis to reduce risk, improve access, and
increase margin. Built on real-world operator experience, ClariVue replaces
fragmented solutions with a unified platform that drives better outcomes for
patients and providers. www.clarivue.io
Crosswalk Health
Crosswalk Health is a virtual-first pulmonary care platform that helps accountable care organizations (ACOs) and risk-bearing primary care groups improve outcomes and reduce total cost of care for patients with chronic obstructive pulmonary disease (COPD) and other chronic respiratory conditions. www.letscrosswalk.com
LifePlus
LifePlus is an early-revenue startup based in Silicon Valley, where a multidisciplinary team of experts in opto-physics, analytical chemistry, signal processing, and AI—working alongside a global network of clinicians—has developed a non-invasive, multi-parameter continuous monitoring device and an end-to-end vertically integrated AI platform designed to drive behavior modification, improve adherence, and deliver better health outcomes. www.lifeplus.ai
Nuvo
Nuvo is redefining pregnancy care with INVU™, the first FDA-cleared, self-administered remote monitoring system. INVU™ empowers expectant mothers to track fetal and maternal health from anywhere, while clinicians receive real-time, clinically accurate data. This reduces clinic visits, streamlines workflows, and ensures better access to quality care—especially for mothers in remote or underserved areas. www.nuvocares.com
Ultrasound AI
Ultrasound AI is the first company to receive FDA De Novo authorization for AI-based delivery-date prediction from routine obstetric ultrasound, transforming the same images clinicians already capture into a more precise, workflow-native layer of prenatal intelligence. www.ultrasound.ai
Cooley Capital Call Judges
Selected companies will each present one three-minute, rapid-fire pitch, followed by a Q&A with the judges and venture capitalists. Presenting companies will also receive one complimentary registration to attend the full DHIS.
DHIS takes place at the Seaport Hotel in Boston from April 27 – 28, 2026. Check out this year’s program.
Please note: This event occurs in a public forum. Members of the press may attend, and audience members may share information on social media.
DHIS co-chair organizations
For more information, please email Sabrina Morales, business development operations manager at Cooley.
